The Student Health Care Amendment Act of 2026 aims to enhance the health care requirements for students in the District of Columbia by amending several existing laws. Key provisions include the establishment of standardized health documentation, specifically a Certificate of Health and an Oral Health Assessment, which must be submitted annually by parents or guardians for students attending public, charter, private, or independent schools. The bill also transfers the responsibility for managing undesignated epinephrine in schools from the Office of the State Superintendent of Education to the Department of Health, ensuring that DC Health oversees the distribution and management of emergency medications. Additionally, the legislation designates the Maryland Poison Center of the University of Maryland School of Pharmacy as the District's official poison control center, replacing the previous designation of the National Capital Poison Center.

Furthermore, the bill repeals certain provisions of the Community Health Omnibus Amendment Act of 2018, specifically those governing the Perinatal and Infant Health Advisory Committee, in light of reforms to the maternal health advisory committee structure. The proposed changes are intended to streamline health documentation processes, clarify the role of the Department of Health in administering emergency medications, and align the law with existing programmatic changes. Overall, the legislation seeks to improve health care access and safety for students while ensuring compliance with updated health standards.